Lactobacillus spp. are a heterogeneous group of microaerophilic grampositive rods, commensal of the gastrointestinal and female genitourinary tracts, and often considered contaminants in blood cultures. However, cases of severe infections caused by these microorganisms have been reported.1 We report a native valve endocarditis and a spondylodiscitis with possible transcatheter aortic valve implantation (TAVI) endocarditis caused by Lactobacillus rhamnosus.
Case 1An 81-year-old male was referred for evaluation of L. rhamnosus bacteremia. He had history of TAVI implantation five months earlier and degenerative lumbar vertebra pathology, and complained of fever and one-month course of asthenia, anorexia and acute worsening of lumbar pain. Four sets of blood cultures (1 set: BACTEC™ Plus Aerobic/F and BACTEC™ Anaerobic/F, BD) were drawn on different days (two sets on the 3rd and two more on the 5th day) which were all positive after 29–42h of incubation. Gram staining showed grampositive rods that were identified as L. rhamnosus by MALDI-TOF directly from positive blood culture (score 1.8). After subculturing and incubation under anaerobic conditions, identification was further confirmed by both MALDI-TOF (score>2) and 16S rRNA gene sequencing. The 16S gene was amplified by PCR using the universal primers (27f and 907r) with conditions previously described.2 The PCR product was purified and sequenced using a BigDye terminator protocol (Applied Biosystems). Sequences were compared with BLAST (http://www.ncbi.nlm.nih.gov/BLAST) and the identification was confirmed (>99% identity) with the 16S rRNA gene sequence of L. rhamnosus LDTM7511 (GenBank accession number CP051227.1). Transesophageal echocardiography was performed and neither vegetations nor valve disfunction was observed. Treatment with ampicillin was initiated. On admission he was afebrile, with holosystolic cardiac murmur and pain at the second lumbar vertebra. Blood cultures after 48h of antibiotic treatment were negative. Antimicrobial susceptibility testing (AST) was carried out following CLSI recommendations (CLSI M45-A2) which also provides interpretative breakpoints for different antibiotics.3 MICs were determined using a broth microdilution method, SensititreTM STRHAE2 (ThermoScientific). The L. rhamnosus isolate was susceptible to penicillin (MIC 2μg/mL), ampicillin (MIC 2μg/mL), erythromycin (MIC<0.25μg/mL), clindamycin (MIC<0.25μg/mL), daptomycin (MIC1μg/mL) and linezolid (MIC<2μg/mL). The isolate did not present high-level gentamicin resistance (gentamicin MIC<500μg/mL) and was resistant to cefotaxime (MIC>2μg/mL) and vancomycin (MIC>16μg/mL). Gentamicin was added to the treatment. Positron emission tomography-computed tomography (PET-CT) showed strong 18-F fluorodeoxyglucose uptake at L1-L2 level without heart valves uptake, although performed 15 days after starting antibiotics. Diagnosis of L. rhamnosus spondylodiscitis and possible TAVI endocarditis was established (Duke criteria: 1 major microbiological criterium, and 2 minor criteria: predisposing heart condition, fever>38°C). Six weeks of treatment with ampicillin were completed, 2 of which in combination with gentamicin. The patient recovered, without relapses after a follow-up of 10 months.
Case 2An 83-year-old woman without relevant background was brought to the emergency department due to syncope. She complained of constitutional symptoms for the past six months. Physical examination showed a holosystolic murmur in mitral focus. Transthoracic echocardiogram showed a vegetation in the posterior mitral leaflet with possible valve rupture and severe mitral regurgitation. Six sets of blood cultures were positive at 26-44h of incubation (four sets the first day and two more, two days after). Microbiological diagnosis, identification and antimicrobial susceptibility testing was performed as described above in case 1. Identification by MALDI-TOF directly from the positive blood culture was unsuccessful, and L. rhamnosus was identified by MALDI-TOF (score>2) directly from colonies after subculturing, and by 16S rRNA gene analysis. The L. rhamnosus isolate was susceptible to penicillin (MIC 2μg/mL), ampicillin (MIC 4μg/mL), erythromycin (MIC<0.25μg/mL) and clindamycin (MIC<0.25μg/mL). Furthermore, the isolate did not show high-level resistance to gentamicin (gentamicin MIC<500μg/mL) as was resistant to cefotaxime (MIC>2μg/mL) and vancomycin (MIC>16μg/mL). She was admitted with the definitive diagnosis of subacute L. rhamnosus endocarditis on mitral native valve (according to Duke criteria, 2 major criteria: microbiological evidence and imaging plus 1 minor criteria: fever) and intravenous penicillin 3 MU every 4h was initiated. A whole-body PET-CT showed no pathological uptakes. Transoesophageal echocardiogram showed rupture of the posterior leaflet of mitral valve. Follow-up blood cultures at 72h of treatment were negative. The patient was considered not suitable for surgery due to advanced age and fragility. Four weeks of penicillin were completed. The patient remained asymptomatic, without relapse after 6 months of follow-up.
Although L. rhamnosus is considered a barely virulent pathogen, cases of endocarditis have been reported.1,4–8,10–20 Infective endocarditis due to Lactobacillus spp. is rare, accounting for less than 0.5% of all episodes. We only found 16 cases of L. rhamnosus endocarditis published since 1980, nevertheless some reported cases of Lactobacillus spp. endocarditis not identified at the species level could also correspond to L. rhamnosus episodes.4 After excluding a pediatric patient and two cases without available information, the 13 remaining cases are detailed in Table 1. Underlying valve disease is the most common predisposing factor, as well as prior gastrointestinal o dental manipulations.5,6 Consumption of probiotics is also considered a potential risk factor,7,8 as specifically described in 6 cases (46.2%). The most frequently affected valve is the aortic (n=9, 69.2%), followed by mitral (n=3, 23.1%). Whereas only three cases (23.1%) involved prosthetic valves, most native valves were anatomically or functionally abnormal.
Infective endocarditis (IE) due to Lactobacillus rhamnosus: summary of case reports.
| Author, publication date | Age, sex | Predisposing factors for bacteremia or IE | Consumption of probiotics | Valve/vertebra involved | Antibiotics | Surgery | Outcome |
|---|---|---|---|---|---|---|---|
| Davies et al., 198612 | 55, M | UK | No | Aortic valve | Penicillin, gentamicin | Yes | Cured |
| Holliman et al., 198813 | 71, F | Prosthetic aortic valve | UK | Prosthetic aortic valve | UK | UK | Death |
| Griffiths et al., 199214 | 45, M | Bicuspid aorta; Dental manipulation | No | Bicuspid aorta | Ampicillin, gentamicin | Yes | Cured |
| Mackay et al., 19997 | 67, M | Mitral valve prolapse with regurgitation | Yes | Mitral valve | Ampicillin, gentamicin | No | Cured |
| Presterl et al., 200115 | 23, M | Bicuspid aorta | Yes | Bicuspid aorta | Penicillin | Yes | Cured |
| Avlami et al., 20016 | 65, M | Colonoscopy | No | Aortic valve | Penicillin, gentamicin | No | Cured |
| Wallet et al., 200216 | 73, M | Prosthetic aortic valve | No | Mitral valve | Amoxicillin, rifampin | Yes | Cured |
| Kochan et al., 20118 | 24, F | Prosthetic aortic valve | Yes | Prosthetic aortic valve | UK | Yes | Cured |
| Felekos et al., 201417 | 74, M | Myxomatous mitral valve | No | Myxomatous mitral valve | Penicillin, gentamicin | Yes | Cured |
| Aaron et al., 20175 | 80, M | Upper endoscopy | No | Aortic and mitral valve | Penicillin, gentamicin | Yes | Cured |
| Noreña et al., 201718 | 28, M | Bicuspid aorta | Yes | Bicuspid aorta | Ampicillin, gentamicin | Yes | Cured |
| Boumis et al., 201819 | 65, M | Hereditary hemorrhagic telangiectasia | Yes | Prosthetic aortic valve | Amoxicillin/clavulanate, gentamicin | No | Cured |
| Naqvi et al., 201820 | 36, F | Cirrhosis | Yes | Aortic valve | Penicillin, gentamicin | Yes | Death |
UK: unknown, not specified in this manuscript.
Closely related, Lactobacillus species are difficult to identify by conventional methods, including MALDI-TOF MS. Therefore, molecular techniques such as 16S rRNA sequencing might be used in combination to achieve a more reliable identification. We suggest that the lack of genus-specific clinical breakpoints for Lactobacillus spp. is a challenge for interpretation of antimicrobial susceptibility testing. For example, EUCAST categorizes this gender into a global grampositive anaerobes group9 and CLSI only defines breakpoints for a few antimicrobials against Lactobacillus spp. In this sense, further studies are required in order to develop reproducible and definitive standards to interpret susceptibility results.
Even though there is no standard treatment, most reports suggest the combination of ampicillin with aminoglycosides. Combination treatment was reported in 10 out of the 13 reviewed cases (76.9%), and surgical intervention was required in 9 cases (69.2%), 8 native and 1 prosthetic valve episodes, most of them operated not during the active phase of treatment (e.g. early valve surgery) but rather to correct the mechanical sequelae with valve dysfunction after finishing antibiotics.
Strains with decreased susceptibility to ampicillin have been found, emphasizing that minimal inhibitory concentration of beta-lactam antibiotics as well as the exclusion of high-level resistance to aminoglycosides are relevant investigations. Eleven patients (84.6%) were cured and 2 (15.4%) died during hospitalization. Only 2 cases of spondylodiscitis have been reported, and one of them was a polymicrobial infection secondary to esophagus perforation. Both cases presented epidural abscess, one requiring surgery and no endocarditis association was described.10,11
No previous cases of TAVI endocarditis and spondylodiscitis have been published up to now. Our report underscores the potential clinical significance of L. rhamnosus bacteremia, highlighting the need for further investigations in patients with an elusive source of the infection.
